Sangam Health Care Products Ltd

Sangam Health Care Products Ltd has announced its 32nd Annual General Meeting (AGM) to be held on September 30, 2026. The company has dispatched the soft copy of the Annual Report for FY 2025-26 and the AGM notice to its members. The agenda includes the adoption of the Audited Financial Statements for FY 2025-26, the reappointment of a director retiring by rotation, and the continuation of a non-executive director's directorship.

Sangam Health Care Products Ltd has announced its 32nd Annual General Meeting (AGM) scheduled for September 30, 2026, at 9:00 AM at its registered office. The AGM will cover ordinary business, including the adoption of the Audited Balance Sheet, Profit & Loss, and Cash Flow Statements for the financial year 2025-26, along with auditor and director reports. A key agenda item is the re-appointment of Mr. A. Sai Balaji Krishna Teja, who retires by rotation. Special business includes considering the continuation of Mrs. Padma Ghanakota's directorship.

Sangam Health Care Products Ltd announced the re-appointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a further period of five years, effective September 5, 2026. This decision was made during a board meeting held on August 13, 2026, and is subject to shareholder approval at the upcoming Annual General Meeting (AGM). The board also approved the unaudited financial results for the quarter ended June 30, 2026, and recommended the reappointment of Mrs. Padma Ghanakota. The 32nd AGM is scheduled for September 30, 2026.

Sangam Health Care Products Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for a five-year term, subject to shareholder approval. The company will convene its 32nd AGM on September 30, 2026, with the register of members and share transfer books closed from September 24 to September 30, 2026.

Sangam Health Care Products Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The board meeting also approved the reappointment of Mr. Bhagat Reddy Dundumulla as Managing Director for five years, subject to shareholder approval. The company will convene its 32nd Annual General Meeting on September 30, 2026, with the register of members and share transfer books closed from September 24 to September 30, 2026.

Sangam Health Care Products Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda items for this meeting include the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026, along with the associated Limited Review Report. The meeting will also address any other business as permitted by the Chair. The company has provided its registered office address and contact details for further correspondence.

Sangam Health Care Products Ltd has announced the closure of its trading window from July 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.

Sangam Health Care Products Ltd's board meeting on May 29, 2026, approved the audited financial results for the quarter and financial year ended March 31, 2026. The board also approved the auditor's report with an unmodified opinion for the same period. The meeting commenced at 3:00 P.M. (IST) and concluded at 3:50 P.M. (IST).

Sangam Health Care Products Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026, along with the audit report for the same period. The meeting will also address any other business with the permission of the Chair.

Sangam Health Care Products Ltd has announced the closure of its trading window for dealing in the securities of the company. The closure will be in effect from 1st April, 2026, and will reopen after 48 hours from the declaration of audited financial results for the quarter and year ending 31.03.2026. The decision is in accordance with the Company's minimum Standards Code of Conduct and the SEBI (Prohibition of Insider Trading) Regulations.